Tidal Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4M Sell
91,944
-101,233
-52% -$15.2M 0.02% 557
2026
Q1
$29.4M Sell
193,177
-33,079
-15% -$5.07M 0.06% 272
2025
Q4
$31.2M Sell
226,256
-75,180
-25% -$9.85M 0.07% 221
2025
Q3
$38.7M Buy
301,436
+292,595
+3,310% +$35.7M 0.08% 199
2025
Q2
$1.07M Buy
8,841
+704
+9% +$79.3K 0.01% 1003
2025
Q1
$907K Buy
8,137
+1,965
+32% +$209K 0.01% 1012
2024
Q4
$601K Buy
6,172
+492
+9% +$52.5K ﹤0.01% 1287
2024
Q3
$653K Buy
5,680
+1,114
+24% +$126K 0.01% 1254
2024
Q2
$486K Buy
4,566
+1,681
+58% +$169K 0.01% 1321
2024
Q1
$279K Buy
+2,885
New +$296K ﹤0.01% 1439

Other funds holding NVS

Tidal Investments's NVS Position: Q2 2026 in Review

Tidal Investments reduced its Novartis (NVS) stake by 52% in Q2 2026, selling an estimated $15.2M and leaving 91,944 shares worth $14.4M. The position accounts for 0.02% of the portfolio, ranked #557.

Tidal Investments first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.7M in Q3 2025. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Tidal Investments held 91,944 shares of Novartis worth $14.4M as of Q2 2026.
  • Tidal Investments sold 101,233 Novartis shares in Q2 2026, an estimated $15.2M.
  • Novartis made up 0.02% of Tidal Investments's portfolio in Q2 2026, its #557 holding.
  • Tidal Investments first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • Tidal Investments's Novartis position peaked at $38.7M in Q3 2025.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.